Bionovate Technologies Corp. announced earnings results for the full year ended June 30, 2020. For the full year, the company announced operating loss was USD 33,055 compared to USD 56,543 a year ago. Net loss was USD 122,045 compared to USD 208,896 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 1.34 a year ago.